---
title: Buy Generic Semaglutide 3mg 7mg 14mg Tablets Online
description: Generic Semaglutide tablets offer effective type 2 diabetes management and weight loss support. Order from our verified online pharmacy.
type: product
language: en 
url: https://liabilis.com/order-semaglutide-online-en.html
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 199.49
price_max: 2009.24
currency: USD
offers:
  - name: 3mg x 10 pills
    price: 199.49
  - name: 3mg x 20 pills
    price: 389.49
  - name: 3mg x 30 pills
    price: 599.99
  - name: 3mg x 60 pills
    price: 1082.99
  - name: 3mg x 90 pills
    price: 1581.74
  - name: 7mg x 10 pills
    price: 239.99
  - name: 7mg x 20 pills
    price: 446.49
  - name: 7mg x 30 pills
    price: 655.49
  - name: 7mg x 60 pills
    price: 1319.99
  - name: 7mg x 90 pills
    price: 1838.24
  - name: 14mg x 10 pills
    price: 246.99
  - name: 14mg x 20 pills
    price: 484.49
  - name: 14mg x 30 pills
    price: 712.49
  - name: 14mg x 60 pills
    price: 1367.99
  - name: 14mg x 90 pills
    price: 2009.24
---

# Buy Generic Semaglutide 3mg 7mg 14mg Tablets Online

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps manage type 2 diabetes by stimulating insulin secretion and suppressing glucagon release. Originally developed by Novo Nordisk, this medication is also used for weight management in adults with obesity or overweight conditions with weight-related medical problems. Our online pharmacy offers generic Semaglutide in 3mg, 7mg, and 14mg tablets for effective diabetes and weight management.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **3mg** | 10 pills | **$199.49** | $19.95 | In Stock |
| **3mg** | 20 pills | **$389.49** | $19.47 | In Stock |
| **3mg** | 30 pills | **$599.99** | $20.00 | In Stock |
| **3mg** | 60 pills | **$1082.99** | $18.05 | In Stock |
| **3mg** | 90 pills | **$1581.74** | $17.57 | In Stock |
| **7mg** | 10 pills | **$239.99** | $24.00 | In Stock |
| **7mg** | 20 pills | **$446.49** | $22.32 | In Stock |
| **7mg** | 30 pills | **$655.49** | $21.85 | In Stock |
| **7mg** | 60 pills | **$1319.99** | $22.00 | In Stock |
| **7mg** | 90 pills | **$1838.24** | $20.43 | In Stock |
| **14mg** | 10 pills | **$246.99** | $24.70 | In Stock |
| **14mg** | 20 pills | **$484.49** | $24.22 | In Stock |
| **14mg** | 30 pills | **$712.49** | $23.75 | In Stock |
| **14mg** | 60 pills | **$1367.99** | $22.80 | In Stock |
| **14mg** | 90 pills | **$2009.24** | $22.32 | In Stock |


[Buy Now](https://liabilis.com/order-semaglutide-online-en.html)

## Introduction 
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist administered as a once-daily oral tablet. It belongs to the class of antidiabetic agents that also aid in weight management. The active ingredient is semaglutide, and the medication is available in pill form at strengths of 3 mg, 7 mg, and 14 mg. Approved therapeutic indications include the treatment of type 2 diabetes mellitus and chronic weight management in adults with obesity or overweight.

## Quick Reference Facts 
**Active Ingredient** 
: Semaglutide 

**Form** 
: pill 3 mg | 7 mg | 14 mg 

**Primary Uses** 
: • Management of type 2 diabetes mellitus 
 • Long-term weight management in adults 

## What is Semaglutide? 
Semaglutide is the generic version of medications containing the active compound semaglutide. It is a synthetic analog of the human incretin hormone GLP-1, engineered to resist degradation by the enzyme dipeptidyl peptidase-4 (DPP-4). The oral formulation is marketed under brand names such as **Rybelsus**, and injectable versions are sold as **Ozempic** and **Wegovy**. The drug was developed by Novo Nordisk and received regulatory approval from the U.S. Food and Drug Administration (FDA) in 2019 for type 2 diabetes and in 2021 for chronic weight management. As a generic product, semaglutide provides the same clinical efficacy and safety profile as its brand-name counterparts while offering potential cost savings for patients.

## How Semaglutide Works 
Semaglutide mimics the action of endogenous GLP-1, a hormone released from the intestinal L-cells in response to nutrient intake. Its principal mechanisms are:

- **Enhancement of glucose-dependent insulin secretion** - when blood glucose rises after a meal, semaglutide stimulates pancreatic β-cells to release insulin, lowering post-prandial glucose levels. 
- **Suppression of inappropriate glucagon release** - it reduces hepatic glucose production by inhibiting α-cell glucagon secretion. 
- **Delayed gastric emptying** - slowing the rate at which food leaves the stomach helps to blunt post-meal glucose spikes and promotes satiety. 
- **Central appetite regulation** - activation of GLP-1 receptors in the hypothalamus reduces hunger, supporting weight loss.

Semaglutide has a prolonged half-life of approximately 1 week for injectable forms; the oral tablet achieves therapeutic concentrations through an absorption enhancer (SNAC) that protects it from gastric degradation. Peak plasma levels occur 1-3 hours after ingestion, and steady-state concentrations are reached after 4-5 weeks of daily dosing.

## Conditions Treated with Semaglutide 

- **Type 2 Diabetes Mellitus** 
 Semaglutide improves glycemic control by lowering HbA1c levels (average reduction 1-1.5 %). It is indicated for adults when diet, exercise, and metformin alone are insufficient. 

- **Chronic Weight Management (Obesity/Overweight)** 
 For patients with a body-mass index ≥ 30 kg/m² (or ≥ 27 kg/m² with weight-related comorbidities), semaglutide promotes sustained weight loss-often > 10 % of initial body weight-by reducing appetite and caloric intake. 

- **Cardiovascular Risk Reduction (Adjunctive)** 
 Clinical trials have demonstrated that semaglutide reduces major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease. While not a primary indication, this benefit informs prescribing decisions for high-risk individuals.

## Is Semaglutide the Right Medication for You? 
Semaglutide is most appropriate for adults with:

- Diagnosed type 2 diabetes whose glycemic targets are not met with first-line therapy. 
- Body-mass index meeting obesity criteria, especially when lifestyle interventions have not produced sufficient weight loss. 
- No personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2). 

Contraindications and cautions include:

- **Pregnancy or breastfeeding** - animal studies show fetal risk; the drug is classified as pregnancy category C. 
- **Severe gastrointestinal disease** - conditions that may impair oral absorption (e.g., gastroparesis) can reduce efficacy. 
- **Renal impairment** - dose adjustment may be required for eGFR < 30 mL/min/1.73 m². 

Patients with a history of pancreatitis, thyroid disorders, or undergoing major surgery should discuss risks with their healthcare professional before initiating therapy.

## Buying Semaglutide from [our online pharmacy](https://liabilis.com/order-semaglutide-online-en.html) 

### Why Choose Our Service? 
Accessing semaglutide can be challenging due to high out-of-pocket costs or limited pharmacy stock. Our platform provides a reliable, cost-effective alternative for patients seeking the generic formulation.

### Quality & Safety Assurance 
We partner with licensed international pharmacies to ensure quality and authenticity. Every batch undergoes verification against regulatory standards before shipment.

### Pricing & Access 
Because we source the generic product directly from reputable manufacturers, the price is often substantially lower than branded alternatives such as Rybelsus. This makes long-term therapy more affordable for individuals managing chronic conditions.

### Discreet Delivery 
Orders are packaged in unmarked, tamper-evident containers and dispatched via express delivery within 7 days or standard airmail in approximately 3 weeks, respecting your privacy at every step.

## Use: Dosing, Missed Dose, Overdose 

- **Starting Dose**: 3 mg orally once daily for the first 30 days. 
- **Titration**: Increase to 7 mg daily after 30 days if additional glycemic control is needed; further increase to 14 mg may be considered for weight-management goals. 
- **Administration**: Take the tablet with a small amount of water (≤ 120 mL) on an empty stomach, at least 30 minutes before the first food, beverage, or other oral medication of the day. 

**Missed Dose** 
If a dose is forgotten, take it as soon as remembered **provided** it is at least 12 hours before the next scheduled dose. Otherwise, skip the missed dose and resume the regular dosing schedule. Do not double-dose.

**Overdose** 
Signs of overdose may include severe nausea, vomiting, or hypoglycemia (especially if combined with insulin or sulfonylureas). Seek immediate medical attention or contact a poison control center. Management is supportive, focusing on hydration and monitoring blood glucose.

## Safety Information 

### ⚠️ Who Should Not Take Semaglutide 
- Individuals with a personal or familial history of medullary thyroid carcinoma (MTC). 
- Patients diagnosed with multiple endocrine neoplasia syndrome type 2 (MEN 2). 
- Known hypersensitivity to semaglutide or any excipients in the tablet. 

### Common Side Effects 
- Nausea (most frequent, typically transient) 
- Vomiting, diarrhea, or constipation 
- Abdominal discomfort and decreased appetite 

These effects are usually mild to moderate and improve with continued therapy. Staying hydrated and eating smaller, balanced meals can mitigate symptoms.

### Serious Side Effects (Seek Immediate Medical Help) 
- **Pancreatitis** - severe abdominal pain radiating to the back, accompanied by nausea or vomiting. 
- **Severe hypoglycemia** - especially when used with insulin or sulfonylureas; symptoms include confusion, sweating, shakiness, and loss of consciousness. 
- **Acute kidney injury** - manifested by reduced urine output, swelling, or rising serum creatinine. 

If any of these occur, discontinue semaglutide and obtain urgent medical care.

### Drug & Food Interactions 
- **Insulin or sulfonylureas** - may increase risk of hypoglycemia; dose adjustments may be required. 
- **Oral medications requiring acidic gastric pH** (e.g., certain antifungals) - semaglutide absorption can be reduced; separate administration by at least 30 minutes. 
- **Warfarin** - no clinically significant interaction reported, but routine INR monitoring is advisable. 

Always inform your healthcare provider about all medicines, supplements, and herbal products you are taking.

## Off-Label and Investigational Uses of Semaglutide 
- **Prediabetes** - early studies suggest semaglutide may delay progression to overt diabetes by improving insulin sensitivity. 
- **Polycystic Ovary Syndrome (PCOS)** - limited trials indicate potential benefits in weight reduction and menstrual regularity, though evidence remains preliminary. 
- **Non-alcoholic fatty liver disease (NAFLD)** - emerging data show reductions in hepatic fat content, but larger studies are needed to confirm efficacy. 

These applications are not approved by regulatory agencies. Use for off-label purposes should occur only under the direct supervision of a qualified healthcare professional.

## Storage & Handling 
- Store tablets at **20-25 °C (68-77 °F)**; excursions between **15-30 °C (59-86 °F)** are acceptable. 
- Keep the container tightly closed, protect from moisture and direct light. 
- Do not use tablets after the printed expiration date. 
- Dispose of unused medication according to local regulations; many pharmacies offer take-back programs.

## Frequently Asked Questions 

**Practical Use & Lifestyle** 

- **Can I travel internationally with semaglutide tablets?** 
 Yes. Keep the medication in its original labeled container, carry it in your carry-on luggage, and be prepared to show proof of legitimacy if requested by customs authorities. 

- **Will alcohol affect how semaglutide works?** 
 Moderate alcohol intake does not significantly alter the drug’s efficacy, but excessive consumption can increase the risk of hypoglycemia, especially when combined with insulin or sulfonylureas. 

**Product & Formulation Details** 

- **What do semaglutide tablets look like?** 
 They are white, round, film-coated tablets marked with the dosage strength (e.g., “3 mg”) on one side. Appearance may vary slightly between manufacturers. 

- **Can I split or crush a semaglutide tablet?** 
 The tablet should be swallowed whole; splitting or crushing may compromise the absorption enhancer and reduce effectiveness. 

**Regulatory & Safety Nuances** 

- **Is semaglutide detectable on standard drug tests?** 
 Semaglutide is not screened for in routine occupational or sports drug testing panels. 

- **Can athletes use semaglutide under WADA rules?** 
 As of the latest World Anti-Doping Agency (WADA) list, GLP-1 receptor agonists are not prohibited, but athletes should verify current regulations before use. 

**Scientific & Clinical Curiosity** 

- **What was the pivotal trial that supported cardiovascular benefit?** 
 The SUSTAIN-6 trial demonstrated a 26 % relative risk reduction in major adverse cardiovascular events among patients with type 2 diabetes receiving semaglutide. 

- **How does oral semaglutide differ from the injectable form?** 
 The oral formulation incorporates the SNAC absorption enhancer to protect the peptide from gastric degradation, allowing once-daily dosing, whereas the injectable version is administered once weekly without an absorption enhancer. 

## Glossary 

**GLP-1 (Glucagon-Like Peptide-1)** 
: An intestinal hormone that stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and promotes satiety. 

**HbA1c** 
: Hemoglobin A1c, a laboratory measure reflecting average blood glucose levels over the previous 2-3 months. 

**DPP-4 (Dipeptidyl Peptidase-4)** 
: An enzyme that rapidly degrades endogenous GLP-1; semaglutide is engineered to resist DPP-4 cleavage, prolonging its activity. 

**SNAP® (Sodium N-[8-(2-hydroxybenzoyl)amino] caprylate)** 
: The proprietary absorption enhancer used in the oral formulation to facilitate semaglutide uptake across the gastric mucosa. 

## Disclaimer 

The information provided about **Semaglutide** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-semaglutide-online-en.html) offers access to **Semaglutide** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.